9 Meters Biopharma's common stock is $1.4K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (March 2023), NMTRQ shows a common stock of $1.4K. That compares with $26K in the prior-year period — down 94.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NMTRQ's common stock is now $1.4K (was $26K) — a 94.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 9 Meters Biopharma is outperforming or lagging.
Tracking NMTRQ's common stock over time shows whether 9 Meters Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4K That compares with $26K in the prior-year period — down 94.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1.4K) with ownership activity and broader fundamentals.
9 Meters Biopharma's common stock is $1.4K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.